MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The role of diabetes mellitus and hyperglycemia in early de novo Parkinson’s disease patients

    S. Polychronis, G. Pagano, M. Politis (London, United Kingdom)

    Objective: To investigate the impact of diabetes mellitus (DM) and hyperglycemia in early de novo (untreated) Parkinson's disease (PD) patients. Background: Patients affected by DM…
  • 2016 International Congress

    Recognition of parkinsonism in African Americans in a community-based sample

    D.A. Hall, B. Ouyang, J.M. Shulman, L.M. Shulman, D.A. Bennett, L.L. Barnes (Chicago, IL, USA)

    Objective: To investigate recognition of parkinsonism in African Americans (AA) in a community-based sample in Chicago. Background: Prior studies suggest that the manifestation of parkinsonism…
  • 2016 International Congress

    A novel interdisciplinary palliative care clinic for advanced Parkinson’s disease and Parkinsonian syndromes

    K.K. Tuck, L. Mann, S. Anderson, T. Borcich, J. Wilhelm, L. Bryans, J. Carter (Portland, OR, USA)

    Objective: We describe a novel interdisciplinary clinic for advanced Parkinson's disease (PD) and Parkinsonian syndromes incorporating palliative care principles to improve quality of life. Background:…
  • 2016 International Congress

    Group meetings for newly diagnosed Parkinson’s disease patients and their spouses: A preliminary experience

    N. Geva, A. Hilel, Y. Manor, S. Arad, A. Ezra, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To estimate the contribution of a group meeting for newly diagnosed PD patients and their spouses. Background: Parkinson's disease (PD) is a common neurodegenerative…
  • 2016 International Congress

    Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients

    D. Cook, C. McRae, R. Kumar (Englewood, CO, USA)

    Objective: To evaluate whether this program improves physical and psychosocial functioning in newly-diagnosed persons with Parkinson's disease (PWP) over the 12-month period of the intervention…
  • 2016 International Congress

    sFIDA: A sensitive diagnostic assay for quantification of α-synuclein aggregates

    T. Bujnicki, C. Zafiu, O. Bannach, D. Willbold (Jülich, Germany)

    Objective: Optimizing of our sFIDA (surface-based fluorescence intensity distribution analysis) assay for specific detection and quantification of single α-synuclein aggregates. Background: Parkinson's disease (PD) is…
  • 2016 International Congress

    Sensor based gait analysis: Diagnostic application for apomorphine titration

    F. Marxreiter, H. Gassner, J. Barth, J. Schlachetzki, C. Thun, D. Volc, J. Winkler, B. Eskofier, J. Klucken (Erlangen, Germany)

    Objective: The goal of the present study was to quantify individual gait changes by eGaIT during the standardized titration test for subcutaneous apomorphine treatment. Background:…
  • 2016 International Congress

    Efficacy and safety of a L-dopa delivery and monitoring medical device

    Y.G. Tirat-Gefen (Fairfax, VA, USA)

    Objective: The objective of this study is to evaluate algorithms in a medical device for l-dopa delivery and monitoring. This wearable medical device will measure…
  • 2016 International Congress

    Analysis of MAPT, GRN and C9orf72 genes in progressive supranuclear palsy, corticobasal syndrome and frontotemporal lobar degeneration in Russian population

    E.Y. Fedotova, N.Y. Abramycheva, M.S. Stepanova, A.S. Vetchinova, S.N. Illarioshkin (Moscow, Russia)

    Objective: To investigate MAPT variants and haplotypes, GRN mutations, and C9orf72 expansion in a cohort of Russian patients with progressive supranuclear palsy (PSP), cotricobasal syndrome…
  • 2016 International Congress

    FBOX07 mutation with juvenile parkinsonism and behavioral disorders

    M. Kuzu, F.N. Durmaz, Ç. Ulukan, H. Kaymakçalan, A.O. Çaglayan, C. Akbostanci (Ankara, Turkey)

    Objective: FBX07 (PARK15) mutations cause juvenile parkinsonism with autosomal ressesive inheritance. Juvenile parkinsonism, pyramidal tract signs and atypical symptoms such as dystonia, chorea, behavioral disturbances,…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley